Acceptability of Nonpharmaceutical Interventions to Prevent the Risk of COVID-19 Infection in the United States.

Rachel E Murray-Watson, Marcy Ekanayake-Weber, Ted Cohen, Janel Hanmer, Reza Yaesoubi

Abstract read

In one paragraph

Article in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rachel E Murray-WatsonDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-9079-5975

Marcy Ekanayake-WeberDepartment of Anthropology, University at Albany, Albany, NY, USA.ORCID https://orcid.org/0000-0001-8131-4738

Ted CohenDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.ORCID https://orcid.org/0000-0002-8091-7198

Janel HanmerDivision of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID https://orcid.org/0000-0001-6159-2482

Reza YaesoubiPhilip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-9276-5750

Funding

A decision tool to inform the optimal use of non-pharmaceutical interventions during the COVID-19 pandemicR21AI173746 · NIAID · YALE UNIVERSITY · PI YAESOUBI, REZA · 2023 to 2024

$460k

NIAID NIH HHS R21 AI173746

6 · The paper itself

Abstract

Highlights: What levels of COVID-19 risk reduction were required for US adults to accept nonpharmaceutical interventions (NPIs) such as school or business closures?In a discrete-choice experiment of 5,047 US adults, mask mandates and other moderate NPIs were broadly acceptable even if they do not reduce cases. School closures without remote learning and closure of nonessential businesses were acceptable only if they reduced infections by ≥75 per 100 persons per month.Our survey participants did not find pandemic response plans that rely on disruptive NPIs acceptable but found indoor mask mandates and school closures with remote learning acceptable, independent of their impact on infection risk.

Indexed as

discrete-choice experimentsnonpharmaceutical interventionspandemicspreferenceutility

Identifiers

PMID42368264

DOI10.1177/23814683261455894

PMCPMC13305725

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.